Global Approvals Analysis: Diabetes, Drug-Eluting Stents Lead List Of Non-US Approvals in October

The CE Marks recorded in October include Abbott's new version of Xience and Medinol's BioNIR drug-eluting coronary stents, plus 18 other devices approved in eight different territories.